Athyrium Capital Management is a specialized asset management firm focusing on structured investments in the global healthcare sector, including biopharma, medical devices, and healthcare services. With over $4.5 billion in committed capital, the company advises funds targeting a range of financial instruments such as royalties, structured credit, and equities, aiming to partner with management teams to fulfill companies' capital needs.
- Healthcare
- Medical Services
- Patient Care
- Preventive Care
- Wellness
- Healthcare Marketing
- Healthcare Communications
- Medical Technology
- Branding
- Data Insights
Recent Transactions involving Athyrium Capital Management
| Deal | Target | Platform | Buyer | Industry |
|---|---|---|---|---|
Unlock Health Announces Acquisition of SPM Group, the Premier Network of Health and Healthcare Marketing Agencies |
SPM Group |
Unlock Health |
Amulet Capital PartnersAthyrium Capital Management |
Healthcare Marketing |
|
|
|
|
||
|
|
|
|
|
The Lower and Middle Market M&A Platform
See how PrivSource can help you close more deals.
Learn more →